Hanbin Li

761 total citations
37 papers, 557 citations indexed

About

Hanbin Li is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Hanbin Li has authored 37 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Hanbin Li's work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Parasitic Infections and Diagnostics (5 papers). Hanbin Li is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Parasitic Infections and Diagnostics (5 papers). Hanbin Li collaborates with scholars based in United States, China and Japan. Hanbin Li's co-authors include Gordon R. Finch, Miodrag Belosevic, Lyndon L. Gyürék, Bert L. Lum, Angelica Quartino, Daniel W. Smith, Amit Garg, Russell Wada, Jin Y. Jin and Daisuke Wada and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Water Research.

In The Last Decade

Hanbin Li

35 papers receiving 530 citations

Peers

Countries citing papers authored by Hanbin Li

Since Specialization

Citations

This map shows the geographic impact of Hanbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbin Li more than expected).

Fields of papers citing papers by Hanbin Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbin Li. The network helps show where Hanbin Li may publish in the future.

Co-authorship network of co-authors of Hanbin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hanbin Li. A scholar is included among the top collaborators of Hanbin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanbin Li. Hanbin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between weight-adjusted-waist index and long-term prognostic outcomes in cardiovascular disease patients: results from the NHANES 1999–2018 study 2025 ·Diabetology & Metabolic Syndrome ·Hanbin Li, (unknown), Hongxin Cheng, Shiqi Wang, Ran Li, Lu Wang, Chengqi He, Wei Quan	6
2	Unlocking the Potential of Extracellular Vesicles in Cardiovascular Disease 2025 ·Journal of Cellular and Molecular Medicine ·Hanbin Li, Lu Wang, Hongxin Cheng, Qing Zhang, (unknown), (unknown), Chengqi He, Quan Wei	2
3	Pulsed electromagnetic fields inhibit atherosclerosis by regulating pyroptosis through membrane tension-mediated mechanosensitive channels 2025 ·Signal Transduction and Targeted Therapy ·Hongxin Cheng, Qing Zhang, (unknown), Hanbin Li, Lu Wang, (unknown), Chengqi He, Chenying Fu, (unknown)	0
4	Pulsed electromagnetic fields treatment ameliorates cardiac function after myocardial infarction in mice and pigs 2025 ·Journal of Advanced Research ·(unknown), Gaiqin Pei, Jiayu Shen, (unknown), Tingyu Chen, Lu Wang, Hongxin Cheng, Hanbin Li, (unknown), (unknown), Qiuling Fan, Chengqi He, Chenying Fu, (unknown), Wei Quan	2
5	The Association Between Neutrophil‐to‐Lymphocyte Ratio, Atherogenic Index of Plasma, and Cardiovascular Disease Incidence 2025 ·Mediators of Inflammation ·Hongxin Cheng, (unknown), Hanbin Li, Lu Wang, Chengqi He, Liyi Huang, Chenying Fu, (unknown)	2
6	Targeting autophagy in doxorubicin-induced cardiotoxicity: A comprehensive review of scientific landscapes and therapeutic innovations 2025 ·Ageing Research Reviews ·(unknown), Lu Wang, Hongxin Cheng, Hanbin Li, Qing Zhang, Chengqi He, Chenying Fu, Quan Wei	3
7	Abstract PO3-04-02: Exposure-efficacy and safety analysis of trastuzumab deruxtecan (T-DXd) in patients with advanced/metastatic HER2+ breast cancer (BC): Analyses from Phase 3 Studies DESTINY-Breast02 (DB-02) and DESTINY-Breast03 (DB-03) 2024 ·Cancer Research ·(unknown), (unknown), Hanbin Li, Helen Kastrissios, Malaz Abutarif, Τushar Garimella, (unknown)	0
8	Population Pharmacokinetics and Exposure–Response Analysis of a Fixed‐Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults 2024 ·Clinical Pharmacology & Therapeutics ·Jaime Algorta, Stella Kepha, Alejandro Krolewiecki, Hanbin Li, (unknown), Pedro Fleitas, Charles Mwandawiro, José Muñóz	1
9	Virtual Reality–Based Training in Chronic Low Back Pain: Systematic Review and Meta-Analysis of Randomized Controlled Trials 2024 ·Journal of Medical Internet Research ·Ran Li, Yinghao Li, (unknown), Hanbin Li, Danrong Hu, Chenying Fu, Quan Wei	14
10	Application of the model‐informed drug development paradigm to datopotamab deruxtecan dose selection for late‐stage development 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), Ying Hong, Naoyuki Tajima, Kashyap Patel, Hanbin Li, (unknown), Jon Greenberg, Adam M. Petrich, Hong Zebger‐Gong, Dale E. Shuster, Pavan Vaddady	3
11	Selinexor population pharmacokinetic and exposure–response analyses to support dose optimization in patients with diffuse large B-cell lymphoma 2021 ·Cancer Chemotherapy and Pharmacology ·Hongmei Xu, Hanbin Li, (unknown), Justin Bader, Shijie Tang, Jatin J. Shah, Sharon Shacham	4
12	Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection 2018 ·Infectious Diseases and Therapy ·Li Zhu, Hanbin Li, Phyllis Chan, Timothy Eley, Yash Gandhi, Marc Bifano, (unknown), (unknown), Eric Hughes, Malaz Abutarif, Richard Bertz, Τushar Garimella	4
13	Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin®), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors 2018 ·Cancer Chemotherapy and Pharmacology ·Angelica Quartino, Hanbin Li, Whitney P. Kirschbrown, (unknown), Daisuke Wada, Amit Garg, Jin Y. Jin, Bert L. Lum	27
14	Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study 2018 ·The Journal of Clinical Pharmacology ·Whitney P. Kirschbrown, Chris Wynne, Matts Kågedal, (unknown), Hanbin Li, Bei Wang, Ihsan Nijem, Tanja Badovinac Črnjević, (unknown), Sarah Heeson, Jennifer Eng‐Wong, Amit Garg	28
15	Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus Infection 2017 ·Clinical Pharmacokinetics ·Phyllis Chan, Hanbin Li, Li Zhu, Marc Bifano, Timothy Eley, (unknown), (unknown), Eric Hughes, Richard Bertz, Τushar Garimella, Malaz Abutarif	11
16	A Model-Based Dose–Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma 2015 ·Journal of Ocular Pharmacology and Therapeutics ·Susan Raber, Jaap W. Mandema, Hanbin Li, Dana J. Nickens	4
17	Population pharmacokinetic and exposure–response analysis for trastuzumab administered using a subcutaneous “manual syringe” injection or intravenously in women with HER2-positive early breast cancer 2015 ·Cancer Chemotherapy and Pharmacology ·Angelica Quartino, Carina Hillenbach, Jing Li, Hanbin Li, Russell Wada, Jennifer Visich, Chunze Li, Dominik Heinzmann, Jin Y. Jin, Bert L. Lum	59
18	Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors 2014 ·Cancer Chemotherapy and Pharmacology ·Amit Garg, Angelica Quartino, Jing Li, Jin Jin, Daisuke Wada, Hanbin Li, Javier Cortés, Virginia McNally, Graham Ross, Jennifer Visich, Bert L. Lum	49
19	Glycated albumin is a potential diagnostic tool for diabetes mellitus 2012 ·Clinical Medicine ·Chun Yang, Hanbin Li, Zhihai Wang, Wanying Zhang, Kun Zhou, (unknown), Ying Zhao, (unknown), Xiaofeng Lv, Hongyan Liang, Xiaofeng Jiang	23
20	Sequential inactivation of cryptosporidium parvum using ozone and chlorine 2001 ·Water Research ·Hanbin Li, Gordon R. Finch, Daniel W. Smith, Miodrag Belosevic	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact